Compare CVS Health Corp (CVS) vs iShares Global Tech ETF (IXN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs iShares Global Tech ETF — how do they compare? CVS Health Corp trades at $106.01 (market cap $135.48B), while iShares Global Tech ETF trades at $138.19. The key difference: CVS Health Corp pays a 2.51% dividend while iShares Global Tech ETF pays none, and CVS Health Corp is trading nearer its 52-week high, iShares Global Tech ETF nearer its low. Which is the better fit depends on your goals.
| CVS | IXN | |
|---|---|---|
Market Cap | $135.48B | — |
Sector | Health | Sector/Thematic |
52-Week High | $106.18 | $149.74 |
52-Week Low | $58.75 | $94.04 |
Enterprise Value | $202.02B | — |
Dividend Yield | 2.51% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
IXN trades at $136.67, down 2.88% over the past day, with a bullish technical signal from moving averages but neutral oscillators. The ETF offers concentrated exposure to global technology leaders, though financial ratios are not provided in the current dataset. A dividend of $0.17 is scheduled for payment on June 18, 2026.
Outlook is mixed; strong tech sector positioning supports growth potential, but high valuations and concentration risks warrant caution. Key catalysts include AI-driven earnings growth, while risks involve market volatility and stretched expectations. Investors should weigh entry points carefully amid current sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About iShares Global Tech ETF
IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.
Read more on IXN →
